SenzaGen AB (OSTO:SENZA) Institutional Ownership : 0.02% (As of May. 05, 2025)

View and export this data going back to 2017. Start your Free Trial

What is SenzaGen AB Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, SenzaGen AB's institutional ownership is 0.02%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, SenzaGen AB's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, SenzaGen AB's Float Percentage Of Total Shares Outstanding is 0.00%.

SenzaGen AB Institutional Ownership Historical Data

The historical data trend for SenzaGen AB's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SenzaGen AB Institutional Ownership Chart

SenzaGen AB Historical Data

The historical data trend for SenzaGen AB can be seen below:

	2024-06-30	2024-07-31	2024-08-31	2024-09-30	2024-10-31	2024-11-30	2024-12-31	2025-01-31	2025-02-28	2025-03-31
Institutional Ownership	0.01	0.01	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02

SenzaGen AB Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

SenzaGen AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SenzaGen AB (OSTO:SENZA) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

Scheeletorget 1, Medicon Village, Building 401, Lund, SWE, 223 81

Website

https://www.senzagen.com

SenzaGen AB markets sells, and performs the in vitro Genomic Allergen Rapid Detection (GARD) sensitization test through its laboratory and licensed Contract Research Organizations (CROs) in Sweden. It offers animal-free testing of chemical compounds in cosmetics, pharmaceuticals, food products, and dyes. It operates in five market segments- Cosmetics, Chemicals, Medical devices, Pharmaceuticals, and Nutrition/food additives. The majority is from the Pharmaceuticals segment. Geographically it operates in North America, Europe, APAC, and RoW, the majority is from Europe.

SenzaGen AB Headlines

No Headlines